Ciprofloxacin treatment of urinary infections results in increased resistance of urinary E. coli to ciprofloxacin and co-trimoxazole

• Autorzy: Borgmann S , Jakobiak T. , Gruber H. , Schroder H. , Sagel U.
• Języki publikacji: EN

Abstrakty

EN

Between 2000 and 2006 the sum of ciprofloxacin and folic acid antagonists prescriptions to Bavarian (South-eastern Germany) outpatients stayed constant. However, prescription numbers of ciprofloxacin increased while those of folic acid antagonists decreased suggesting an apparent shift in the treatment of urinary infections toward ciprofloxacin. During the observation period the proportion of E. cbti resistant against ciprofloxacin increased from 5% to 10% while that against co-trimoxazole increased from 21 % to 27%. The proportion of E. coli simultaneously exhibiting resistance to ciprofloxacin and co-trimoxazole increased from 3.9% to 8.5%. A leading influence of ciprofloxacin application for these developments is discussed.

Słowa kluczowe

EN

pathogen; antibiotic prescription; treatment; co-trimoxazole; Escherichia coli; urinary infection; ciprofloxacin

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2009
• Tom: 58
• Numer: 4
• Opis fizyczny: p.371-373,fig.,ref.

Twórcy

autor

Borgmann S

• Synlab Medical Care Centre Weiden, Zur Kesselschmiede 4, D-92637 Weiden, Germany

autor

Jakobiak T.

autor

Gruber H.

autor

Schroder H.

autor

Sagel U.

Bibliografia

• Borgmann S., T. Jakobiak, H. Gruber, H. Schröder and U. Sagel. 2009. Prescriptions of broad-spectrum antibiotics to outpatients do not match increased prevalence and antibiotic resistance of respiratory and urinary pathogens in Bavaria ( Southern Germany). Pol. J. Microbiol. 58: 105-1 10.
• Farra A., G. Skoog, L. Wallén, G. Kahlmeter, G. Kronvall, M. Sörberg and Swebact Study Group. 2002. Antibiotic use and Escherichia coli resistance trends forquinolones and cotrimoxazole in Sweden. Scand. J. Infect. Dis. 34: 449-455.
• Huang E.S. and R.S. Stafford. 2002. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch. Intern. Med. 162: 41-47.
• Kahlmeter G. and P. Menday. 2003. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J. Antimicrob. Chemother. 52: 128-131.
• Karlowsky J.A., D.J. Hoban, M.R. Decorby, N.M. Laing and G.G. Zhanel. 2006. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Antimicrob. Agents Chemother. 50: 2251-2254.
• Kern W.V. and Schröder H. 2008. Antibiotic consumption in human medicine. 2.1. Antibiotic consumption in ambulatory settings (in German). In: Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., 8. Infektiologie Freiburg Eds. GERMAP 2008. Antibiotic resistance and consumption (in German). Antiinfectives Intelligence, Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH, Rheinbach, Germany
• Kresken M. and Straube E. 2008. Antibiotic resistance in human medicine (in German) 4.1.4. Haemophilus influenzae. In: Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., Infektiologie Freiburg Eds. GERMAP 2008. Antibiotic resistance and consumption (in German). Antiinfectives Intelligence, Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH, Rheinbach, Germany
• Livermore D.M., P. Stephens, J. Weinberg, A.P. Johnson, T. Gifford, D. Northcott, D. James, R.C. George and D.C. Speller. 2000. Regional variation in ampicillin and trimethoprim resistance in Escherichia coli in England from 1990 to 1997, in relation to antibacterial prescribing.J. Antimicrob. Chemother. 46: 411-422.